← Leaderboards
Gadiparthi N Rao
University Of Tennessee Health Sci Ctr
$27,893,715
Attributed
$27,893,715
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,893,715 · 6
By mechanism
R01$27,893,715 · 6
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingResponsePlayBlood VesselsSignal TransductionEventMigrationAtherosclerosisDominant-Negative MutationBaseSmall Interfering RnaEndothelial CellsCell MotilityResearch StudyProteinsRestenosisApplications GrantsMolecularInflammationFundingPathogenesisVascular DiseasesCell ProliferationTime Study
Grant awards (78)
GRP78 signaling and retinal angiogenesis$511,066
R01 · FY2025 · EY · contact PI
GRP78 signaling and retinal angiogenesis$511,066
R01 · FY2024 · EY · contact PI
GRP78 signaling and retinal angiogenesis$511,066
R01 · FY2023 · EY · contact PI
Mechanisms of retinal angiogenesis$331,740
R01 · FY2021 · EY · contact PI
Lipid mediators and vascular diseases$412,640
R01 · FY2020 · HL · contact PI
Mechanisms of retinal angiogenesis$342,000
R01 · FY2020 · EY · contact PI
GPCR Signaling and Vascular Wall Remodeling$475,866
R01 · FY2019 · HL · contact PI
Lipid mediators and vascular diseases$412,640
R01 · FY2019 · HL · contact PI
NFATs and Vascular Injury$380,000
R01 · FY2019 · HL · contact PI
Mechanisms of retinal angiogenesis$304,000
R01 · FY2019 · EY · contact PI
GPCR Signaling and Vascular Wall Remodeling$475,866
R01 · FY2018 · HL · contact PI
Lipid mediators and vascular diseases$412,640
R01 · FY2018 · HL · contact PI
NFATs and Vascular Injury$380,000
R01 · FY2018 · HL · contact PI
Mechanisms of retinal angiogenesis$342,000
R01 · FY2018 · EY · contact PI
GPCR Signaling and Vascular Wall Remodeling$475,866
R01 · FY2017 · HL · contact PI
Lipid mediators and vascular diseases$412,640
R01 · FY2017 · HL · contact PI
NFATs and Vascular Injury$380,000
R01 · FY2017 · HL · contact PI
Mechanisms of retinal angiogenesis$304,000
R01 · FY2017 · EY · contact PI
GPCR Signaling and Vascular Wall Remodeling$451,941
R01 · FY2016 · HL · contact PI
NFATs and Vascular Injury$380,000
R01 · FY2016 · HL · contact PI
Eicosanoids and Vascular Wall Remodeling$375,000
R01 · FY2016 · HL · contact PI
Mechanisms of retinal angiogenesis$337,500
R01 · FY2016 · EY · contact PI
GPCR Signaling & Vascular Wall Remodeling$456,239
R01 · FY2015 · HL · contact PI
Eicosanoids and Endothelial Cell Dysfunction$369,375
R01 · FY2015 · HL · contact PI
Eicosanoids and Vascular Wall Remodeling$369,375
R01 · FY2015 · HL · contact PI
NFATs and Vascular Injury$364,450
R01 · FY2015 · HL · contact PI
Mechanisms of retinal angiogenesis$330,750
R01 · FY2015 · EY · contact PI
GPCR Signaling & Vascular Wall Remodeling$453,923
R01 · FY2014 · HL · contact PI
Eicosanoids and Vascular Wall Remodeling$367,500
R01 · FY2014 · HL · contact PI
Eicosanoids and Endothelial Cell Dysfunction$367,500
R01 · FY2014 · HL · contact PI
NFATs and Vascular Injury$362,600
R01 · FY2014 · HL · contact PI
Mechanisms of retinal angiogenesis$337,500
R01 · FY2014 · EY · contact PI
GPCR Signaling & Vascular Wall Remodeling$440,954
R01 · FY2013 · HL · contact PI
Mechanisms of retinal angiogenesis$375,000
R01 · FY2013 · EY · contact PI
Eicosanoids and Vascular Wall Remodeling$357,000
R01 · FY2013 · HL · contact PI
Eicosanoids and Endothelial Cell Dysfunction$357,000
R01 · FY2013 · HL · contact PI
NFATs and Vascular Injury$352,240
R01 · FY2013 · HL · contact PI
GPCR Signaling & Vascular Wall Remodeling$463,187
R01 · FY2012 · HL · contact PI
Eicosanoids and Endothelial Cell Dysfunction$374,688
R01 · FY2012 · HL · contact PI
NFATs and Vascular Injury$370,000
R01 · FY2012 · HL · contact PI
Eicosanoids and Vascular Wall Remodeling$349,750
R01 · FY2012 · HL · contact PI
GPCR Signaling & Vascular Wall Remodeling$438,932
R01 · FY2011 · HL · contact PI
EICOSANOIDS AND VASCULAR WALL REMODELING$365,000
R01 · FY2011 · HL · contact PI
15-LOX-15(S)-HETE axis and angiogenesis$365,000
R01 · FY2011 · HL · contact PI
NFATs and Vascular Injury$358,000
R01 · FY2011 · HL · contact PI
Phospholipases and retinal angiogenesis$319,680
R01 · FY2011 · EY · contact PI
NFATs AND VASCULAR INJURY$365,000
R01 · FY2010 · HL · contact PI
EICOSANOIDS AND VASCULAR WALL REMODELING$365,000
R01 · FY2010 · HL · contact PI
15-LOX-15(S)-HETE axis and angiogenesis$365,000
R01 · FY2010 · HL · contact PI
Phospholipases and retinal angiogenesis$329,670
R01 · FY2010 · EY · contact PI
15-LOX-15(S)-HETE axis and angiogenesis$365,000
R01 · FY2009 · HL · contact PI
EICOSANOIDS AND VASCULAR WALL REMODELING$365,000
R01 · FY2009 · HL · contact PI
NFATs AND VASCULAR INJURY$365,000
R01 · FY2009 · HL · contact PI
Phospholipases and retinal angiogenesis$311,400
R01 · FY2009 · EY · contact PI
NFATs AND VASCULAR INJURY$365,000
R01 · FY2008 · HL · contact PI
EICOSANOIDS, ANGIOGENESIS, AND RETINOPATHY$347,327
R01 · FY2008 · EY · contact PI
15-LOX-15(S)-HETE axis and angiogenesis$342,000
R01 · FY2008 · HL · contact PI
EICOSANOIDS AND VASCULAR WALL REMODELING$342,000
R01 · FY2008 · HL · contact PI
EICOSANOIDS, ANGIOGENESIS, AND RETINOPATHY$354,415
R01 · FY2007 · EY · contact PI
Non-COX Arachidonic Acid Metabolites and Angiogenesis$346,086
R01 · FY2007 · HL · contact PI
NFATs AND VASCULAR INJURY$344,880
R01 · FY2007 · HL · contact PI
PHOSPHOLIPASE A2 AND VASCULAR WALL REMODELING$276,869
R01 · FY2007 · HL · contact PI
Non-COX Arachidonic Acid Metabolites and Angiogenesis$356,423
R01 · FY2006 · HL · contact PI
EICOSANOIDS, ANGIOGENESIS, AND RETINOPATHY$349,185
R01 · FY2006 · EY · contact PI
PLA2 AND VASCULAR WALL REMODELING$285,138
R01 · FY2006 · HL · contact PI
Non-COX Arachidonic Acid Metabolites and Angiogenesis$365,000
R01 · FY2005 · HL
PLA2 AND VASCULAR WALL REMODELING$292,000
R01 · FY2005 · HL
NFATs and Vascular Injury$286,000
R01 · FY2005 · HL
PHOSPHOLIPASE A2 AND VASCULAR WALL REMODELING$342,000
R01 · FY2004 · HL
Non-COX Arachidonic Acid Metabolites and Angiogenesis$292,000
R01 · FY2004 · HL
NFATs and Vascular Injury$286,000
R01 · FY2004 · HL
NFATs and Vascular Injury$286,000
R01 · FY2003 · HL
PLA2, EICOSANOIDS AND VASCULAR REMODELING$234,064
R01 · FY2003 · HL
NFATs and Vascular Injury$311,000
R01 · FY2002 · HL
PLA2, EICOSANOIDS AND VASCULAR REMODELING$227,247
R01 · FY2002 · HL
PLA2, EICOSANOIDS AND VASCULAR REMODELING$220,629
R01 · FY2001 · HL
PLA2, EICOSANOIDS AND VASCULAR REMODELING$150,570
R01 · FY2000 · HL
PLA2, EICOSANOIDS AND VASCULAR REMODELING$75,632
R01 · FY2000 · HL